Accumulation / Pre-Breakout Alert: Nuvilex, Inc (NVLX)
Last week was a very good one for us. We saw 200%+ gains in WRIT and a 25%+ gain in IWEB to close the week out.
Now we turn our attention to an alert we’ve previously profiled because it is looking stronger than ever..
Check out Nuvilex,
Inc (NVLX) right now.
NVLX is consolidating sideways in a fairly tight range and buyers accumulate in anticipation of a breakout.
NVLX has an amazingly bullish medium-long term chart. Take a look below.
You will see a strong upward trend over the past six months or so. You will also note that NVLX is trading well above its 200dma and its 50dma continues to act as strong support.
Having closed at $0.145 on Friday, NVLX closed above its 50 day average and its trend line has been kept in tact.
Multi-year highs in NVLX are around $0.22. Given its current trend, we could very well expect NVLX to
test this level in the coming day(s), and just as another alert we
previously gave you (PLPL), break through to new multi-year highs above
we alerted you to PLPL just a couple of months ago at $0.51 – well it
has since gone on to hit a high of $0.80 – a very strong 57% gain.
NVLX is showing all the same characteristics as PLPL.
A move to $0.22 would mean a 52% gain – very good considering NVLX is not particularly volatile, representing an excellent risk/reward profile.
NVLX has been on a steady climb higher over the past six months as buzz surrounding this biotech company increases.
NVLX (Nuvilex, Inc.) is
a biotechnology and life technology company, which develops and markets
products to improve the health, condition, and well-being of people
around the world.
NVLX offers Cinnechol, a natural supplement, which
helps in maintaining normal cholesterol levels and supports normal
NVLX also offers Cinnergen, a liquid whole food
nutritional supplement that provides nutrients to help the body process
glucose; Cinnsational, a liquid nutritional supplement, which helps the
body to combat symptoms associated with alcohol sensitivity, including
nausea, fatigue, and headaches; and Citroxin, a surface cleaner for
bacterial health threats, as well as an antiviral cleaner against swine
flu virus and bird flu virus.
NVLX is developing cell therapy products and has completed its Phase 2 clinical trials. NVLX sells its products directly through its Websites, as well as through resellers and retail distributors.
NVLX has been a provider of all-natural products for many years. The company has
been expanded to increase its natural product-based footprint through medical
marijuana studies. They are an international biotechnology provider of live,
therapeutically valuable, encapsulated cells and services for research and
medicine. New developments by NVLX
and subsidiaries will be substantial as they have been working
on many fronts to move forward. NVLX’s
offerings will ultimately include cancer, diabetes and other treatments using
the Company’s natural product knowledge, product base, cell and gene therapy
expertise, and live-cell encapsulation technology in addition to other new
products currently under development.
NVLX has also
benefited tremendously from a recent CNN program hosted by Dr Sanjay
Gupta. Dr Gupta’s documentary, Weed, which aired on Sunday, August 11 at
8 p.m. ET on CNN, took a very hard look at the effects and benefits of
the drug, for which Dr Gupta, CNN’s chief medical correspondent,
apologized for his earlier stance against the drug, stating "… I
apologize because I didn’t look hard enough, until now."
You can learn more about NVLX at their website at www.nuvilex.com.
There has been a lot of news, research and analysis hitting the wires on NVLX recently, you can read it all below.
We think there is plenty of upside left in NVLX over the short to medium term. Buying at these levels could allow members to be a part of NVLX before a potentially parabolic breakout occurs if it clears $0.22
proven itself to be very trader friendly. It has shown some substantial short
and long term gains, and it has tremendous liquidity and strong underlying
I’ll keep you updated on any news or thought as it comes to hand.
Click Below to Join Our Social Media Networks
————————————————————————————- DISCLAIMER —————————————————————————————
Never invest in any stock featured on our site or emails unless you can afford
to lose your entire investment.
Full disclaimer can be read at
Pennystockgeneral.com employees are not registered as an Investment Adviser in
any jurisdiction whatsoever.
The disclaimer is to be read and fully understood before using our site, or
joining our email list.
None of the materials or advertisements herein constitute offers or
solicitations to purchase or sell securities of the companies profiled herein
and any decision to invest in any such company or other financial decisions
should not be made based upon the information provide herein. Instead pennystockgeneral.com strongly urges
you conduct a complete and independent investigation of the respective
companies and consideration of all pertinent risks. Pennystockgeneral.com does not offer such advice or analysis, and pennystockgeneral.com further urges
you to consult your own independent tax, business, financial and investment
advisors. Investing in micro-cap and growth securities is highly speculative
and carries and extremely high degree of risk. It is possible that an
investor’s investment may be lost or impaired due to the speculative nature of
the companies profiled.
Any statements that express or involve discussions with respect to predictions,
expectations, beliefs, plans, projections, objectives, goals, assumptions or
future events or performance are not statements of historical fact may be
"forward looking statements". Forward looking statements are based on
expectations, estimates, and projections at the time the statements are made
that involve a number of risks and uncertainties which could cause actual
results or events to differ materially from those presently anticipated.
Forward looking statements in this action may be identified through use of
words such as "projects", "foresee", "expects",
"will", "anticipates", "estimates",
"believes", "understands", or that by statements indicating
certain actions "may", "could", or "might" occur.
Understand there is no guarantee past performance will be indicative of future
In preparing this publication, pennystockgeneral.com
has relied upon information supplied by its customers, and press releases which
it believes to be reliable; however, such reliability cannot be guaranteed.
Investors should not rely on the information contained in this website. Rather,
investors should use the information contained in this website as a starting
point for doing additional independent research on the featured companies. The
advertisements in this website are believed to be reliable, however, pennystockgeneral.com and its owners,
affiliates, subsidiaries, officers, directors, representatives and agents
disclaim any liability as to the completeness or accuracy of the information
contained in any advertisement and for any omissions of materials facts from
such advertisement. Pennystockgeneral.com
is not responsible for any claims made by the companies advertised herein.
receive compensation and its employees and affiliates may own stock that they
have purchased in the open market either prior, during, or after the release of
the companies profile which is an inherent conflict of interest in pennystockgeneral.com statements and
opinions and such statements and opinions cannot be considered independent. Pennystockgeneral.com and its
management may benefit from any increase in the share price of the profiled
companies and hold the right to sell the shares bought at any given time
including shortly after the release of the companies profile. PSG has been
compensated two thousand dollars from a third party, Cream Consulting,
for this one day profile of NVLX. PSG has previously been compensated
for profiles of PLPL, IWEB and WRIT.
may on occasion accept compensation in free-trading shares for it’s marketing
services of the company being profiled, and the third party that might have
may hold free-trading shares of the company being profiled and could very well
be selling shares of the companies stock at the same time the profile is being
disseminated to potential investors; this should be viewed as a definite
conflict of interest and as such, the reader should take this into
consideration. If Pennystockgeneral.com
ever accepts compensation in the form of free trading shares of the company
being profiled and decides to sell these shares into the public market at any
time before, during, or after the release of the companies profile our
disclaimer will be updated accordingly reflecting the current position of those
free trading shares received as compensation for our services.
/* Style Definitions */
mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Times New Roman";